Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer : The tarceva lung cancer investigation trialPLUZANSKA, Anna; SZCZESNA, Aleksandra; JANASKOVA, Terezie et al.Journal of clinical oncology. 2007, Vol 25, Num 12, pp 1545-1552, issn 0732-183X, 8 p.Article

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III TrialSCAGLIOTTI, Giorgio V; KRZAKOWSKI, Maciej; PAPAI, Zsolt S et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, issn 0732-183X, 9 p.Article

The EvA study: aims and strategyZIEGLER-HEITBROCK, Loems; FRANKENBERGER, Marion; SINGH, Dave et al.The European respiratory journal. 2012, Vol 40, Num 4, pp 823-829, issn 0903-1936, 7 p.Article

High VEGFR-3-positive Circulating Lymphatic/Vascular Endothelial Progenitor Cell Level Is Associated with Poor Prognosis in Human Small Cell Lung CancerBOGOS, Krisztina; RENYI-VAMOS, Ferenc; LANG, Gyorgy et al.Clinical cancer research (Print). 2009, Vol 15, Num 5, pp 1741-1746, issn 1078-0432, 6 p.Article

Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinibSCHWAB, Richard; PINTER, Ferenc; MANGEL, Laszlo et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7736-7738, issn 0732-183X, 3 p.Article

Efficacy of gemcitabine : Cisplatin treatment in stage IIIA (bulkyN2), IIIB and IV non-small cell lung cancerOSTOROS, Gyula; SZONDY, Klara; GERGELY-FARNOS, Erzsébet et al.Anticancer research. 2005, Vol 25, Num 1B, pp 471-475, issn 0250-7005, 5 p.Article